Pharmatek adds spray drying to drug manufacturing capabilities

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Law to Decentralize Personalized Drug Manufacturing in UK

A legislation to decentralize personalized drug manufacturing in UK...

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

AstraZeneca announces $50 billion of investment in the United...

Energy efficiency in pure steam generation: How small adjustments can lead to big savings

Pharmaceutical manufacturers face a twofold challenge. They not only...

Pharmatek Laboratories, a pharmaceutical chemistry development company, has added spray drying to its drug formulation and manufacturing capabilities.Pharmatek has acquired a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.
The technology can be used for both oral and parenteral dosage forms.

Spray drying allows coating of particles, creating matrices of drug and polymers (spray dried dispersion), and manufacturing of microcapsules, in addition to converting liquid solutions or suspensions into solids in a single process step.

Pharmatek CEO and CSO Jeffrey Bibbs said spray drying not only forms an integral technology in the company’s toolkit for formulating insoluble compounds, it even offers variety of advantages such as enhanced robustness and reproducibility, ability to control and create uniform particle size, and stabilize volatile and thermo-sensitive compounds.

Pharmatek president Tim Scott said adding spray drying to the drug development toolkit provides another degree of sophistication to Pharmatek’s broad array of formulation technologies and equipment.

 

Latest stories

Related stories

Law to Decentralize Personalized Drug Manufacturing in UK

A legislation to decentralize personalized drug manufacturing in UK...

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

AstraZeneca announces $50 billion of investment in the United...

Energy efficiency in pure steam generation: How small adjustments can lead to big savings

Pharmaceutical manufacturers face a twofold challenge. They not only...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back